Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and G-CSF for diminished ovarian reserve in IVF candidates
IRCT20151013024512N8Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of platelet-rich plasma and granulocyte colony-stimulating factor in Diminished Ovarian Reserve (DOR) and infertility (3 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Chemical pregnancy rate, Clinical pregnancy rate and 6 more. Started May 2025; status: completed.
02
Drugs
platelet-rich plasmagranulocyte colony-stimulating factor
03
Conditions
Diminished Ovarian Reserve (DOR)infertility
Beyond the preview
Go deeper on IRCT20151013024512N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151013024512N8.